Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphoma

被引：2
|
作者：
Chirico, A. [1 ]
Henderson Berg, M. H. [1 ]
Roberge, D. [2 ]
Pehr, K. [1 ]
机构：
[1] McGill Univ, Div Dermatol, Montreal, PQ, Canada
[2] CHUM Hotel Dieu Montreal, Div Radiat Oncol, Montreal, PQ, Canada
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 184卷 / 02期
关键词：
D O I：
10.1111/bjd.19490
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：354 / 356
页数：3
相关论文
共 50 条
  • [21] Intralesional corticosteroid therapy for primary cutaneous B-cell lymphoma
    Perry, A.
    Vincent, B. J.
    Parker, S. R. S.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (01) : 223 - 225
  • [22] Primary Cutaneous Marginal Zone B-Cell Lymphoma Treated with Intralesional Rituximab: Experience of a Single Center
    Domingo-Domenech, Eva
    Salas, Queralt
    Climent, Fina
    Aguilera, Carmen
    Pomares, Helena
    Gonzalez-Barca, Eva
    Mercadal, Santiago
    Lucas, Anna
    Fernandez de Sevilla, Alberto
    Sureda, Anna
    Servitje, Octavio
    BLOOD, 2015, 126 (23)
  • [23] Treatment of refractory cutaneous B-cell lymphoid hyperplasia with intralesional rituximab
    Laube, Simone
    Al-Qsous, Wael
    EUROPEAN JOURNAL OF CANCER, 2023, 190 : S46 - S46
  • [24] Indolent cutaneous B-cell lymphoma: diagnosis and treatment 2012
    Santucci, M.
    Grandi, V.
    Maio, V.
    Delfino, C.
    Alterini, R.
    Pimpinelli, N.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2012, 147 (06): : 581 - 588
  • [25] Re-treatment of relapsed indolent B-cell lymphoma with rituximab
    Igarashi, T
    Ohtsu, T
    Fujii, H
    Sasaki, Y
    Morishima, Y
    Ogura, M
    Kagami, Y
    Kinoshita, T
    Kasai, M
    Kiyama, Y
    Kobayashi, Y
    Tobinai, K
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 73 (02) : 213 - 221
  • [26] Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
    Tadahiko Igarashi
    Tomoko Ohtsu
    Hirofumi Fujii
    Yasutsuna Sasaki
    Yasuo Morishima
    Michinori Ogura
    Yoshitoyo Kagami
    Tomohiro Kinoshita
    Masaharu Kasai
    Yoshio Kiyama
    Yukio Kobayashi
    Kensei Tobinai
    International Journal of Hematology, 2001, 73 : 213 - 221
  • [27] MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma
    Monsalvez, Veronica
    Montes-Moreno, Santiago
    Artiga, Maria J.
    Rodriguez, Maria E.
    Espiridion, Beatriz S.
    Lozano, Maria
    Fernandez-de-Misa, Ricardo
    Rodriguez-Peralto, Jose L.
    Piris, Miguel A.
    Ortiz-Romero, Pablo L.
    MODERN PATHOLOGY, 2013, 26 (02) : 171 - 181
  • [28] Primary cutaneous B-cell lymphoma treated with systemic rituximab
    Besch-Stokes, Jake
    Bhullar, Puneet
    Puri, Pranav
    Boudreaux, Blake
    Costello, Collin
    Rule, William
    Rosenthal, Allison
    DiCaudo, David J.
    Pittelkow, Mark R.
    Mangold, Aaron
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB194 - AB194
  • [29] Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma
    Heinzerling, L
    Dummer, R
    Kempf, W
    Schmid, MH
    Burg, G
    ARCHIVES OF DERMATOLOGY, 2000, 136 (03) : 374 - 378
  • [30] Low-grade cutaneous B-cell lymphoma:: Failure of intralesional rituximab (Mabthera®)
    Abasq, C.
    Duval-Modeste, A. -B.
    Courville, P.
    Joly, P.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2008, 135 (6-7): : 509 - 511
12345